Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Feline leukemia virus vaccine development.

× No keyword cloud information.

5 in total

1. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

Authors: L Hanlon; D Argyle; D Bain; L Nicolson; S Dunham; M C Golder; M McDonald; C McGillivray; O Jarrett; J C Neil; D E Onions
Journal: J Virol Date: 2001-09 Impact factor: 5.103

2. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.

Authors: Luc DesCôteaux; Dominique Cécyre; Johanne Elsener; Guy Beauchamp
Journal: Can Vet J Date: 2003-10 Impact factor: 1.008

3. A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.

Authors: Lucy H O'Donovan; Elizabeth L McMonagle; Samantha Taylor; Derek Bain; Angela M Pacitti; Mathew C Golder; Michael McDonald; Linda Hanlon; David E Onions; David J Argyle; Oswald Jarrett; Lesley Nicolson
Journal: Vaccine Date: 2005-03-16 Impact factor: 3.641

4. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax^® Lv-K and Fel-O-Vax^® 5).

Authors: Mark Westman; Jacqueline Norris; Richard Malik; Regina Hofmann-Lehmann; Yasmin A Parr; Emma Armstrong; Mike McDonald; Evelyn Hall; Paul Sheehy; Margaret J Hosie
Journal: Viruses Date: 2021-02-03 Impact factor: 5.048

5. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax^® FIV).

Authors: Mark Westman; Dennis Yang; Jennifer Green; Jacqueline Norris; Richard Malik; Yasmin A Parr; Mike McDonald; Margaret J Hosie; Sue VandeWoude; Craig Miller
Journal: Viruses Date: 2021-03-12 Impact factor: 5.048

5 in total

Feline leukemia virus vaccine development.

1. Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors.

2. Comparison of humoral immune responses in dairy heifers vaccinated with 3 different commercial vaccines against bovine viral diarrhea virus and bovine herpesvirus-1.

3. A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.

4. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax® Lv-K and Fel-O-Vax® 5).

5. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax® FIV).

4. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax^® Lv-K and Fel-O-Vax^® 5).

5. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax^® FIV).